WhatsApp
Facebook X-twitter Linkedin Youtube Instagram
Dr Swati Shah - Uro and Gynec Cancer Surgeon Logo
Dr Swati Shah - Uro and Gynec Cancer Surgeon Logo
+91 63555 64601

Predicting Survival After Bladder-Preserving Treatment

You are here >> Home > Latest Updates > Urinary Bladder Cancer > Predicting Survival…

Development and external validation of a nomogram predicting cancer-specific mortality-free survival after trimodal therapy in muscle-invasive bladder cancer.DOI 10.1007s00

Muscle-invasive bladder cancer is a serious disease. Many patients need strong treatment to control it. One option is trimodal therapy. This approach keeps the bladder and combines surgery to remove the tumor, radiation therapy, and chemotherapy. It helps some patients avoid full bladder removal.

Patients often ask an important question. What are my chances after this treatment? Doctors use staging systems to estimate risk. These systems group patients based on how far the cancer has spread. They help guide care. They do not always reflect each person’s situation.

This new study looked at a different way to predict outcomes. Researchers created a tool called a nomogram. A nomogram uses several personal and tumor details to estimate risk. The study included over 1,800 people treated with trimodal therapy across the United States.

The tool used simple information. This included age, sex, tumor size, cancer stage, lymph node status, and even neighborhood income level. By combining these details, the nomogram estimated the chance of dying from bladder cancer over time.

The researchers tested the tool in two separate patient groups. This step checked if it worked well outside the original data. The results showed better accuracy than standard staging alone. The nomogram gave clearer predictions at two, three, and four years after treatment. It also matched well with what actually happened to patients.

This does not mean the tool is perfect. Predictions were helpful but not exact. Cancer is complex, and no model can predict the future for every patient. Still, this approach offers more personal information than older methods.

For patients, this matters during shared decision-making. A clearer estimate can guide follow-up plans and discussions about risks and benefits. It may also help patients feel more informed about their care path.

Tools like this are not a replacement for doctor advice. They support conversations and planning. As research improves, predictions may become even more personal and useful for people choosing bladder-preserving treatment.

DOI: 10.1007/s00345-026-06217-3

Rate this post
dr swati shah - uro & gynec cancer surgeon
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.